Statute Details
- Title: Medical (Therapy, Education and Research) (Approved Hospitals and Medical Schools) Notification 2010
- Act Code: MTERA1972-N1
- Type: Subsidiary Legislation (SL)
- Authorising Act: Medical (Therapy, Education and Research) Act 1972
- Key Provision: Section 2 (Minister’s declaration of approved hospitals and medical schools)
- Current Version: Current version as at 27 Mar 2026 (with a 2025 Revised Edition available)
- Revised Edition: 2025 Revised Edition (2 June 2025)
- Original Citation: SL 575/2010 (17 February 2010)
- Amendment History (selected): S 575/2010 (11 Oct 2010); S 562/2015 (21 Sep 2015); S 566/2018 (19 Sep 2018); S 412/2024 (15 May 2024)
What Is This Legislation About?
The Medical (Therapy, Education and Research) (Approved Hospitals and Medical Schools) Notification 2010 is a Singapore subsidiary legal instrument that identifies which institutions are “approved” for the purposes of the Medical (Therapy, Education and Research) Act 1972. In practical terms, it is an administrative-but-legal mechanism: rather than creating broad policy from scratch, it designates specific hospitals and medical schools that qualify under the parent Act’s regulatory framework.
The parent Act (Medical (Therapy, Education and Research) Act 1972) is concerned with the lawful use of human tissue and related matters for therapy, education, and research. The Notification plays a narrower role: it determines the institutional gatekeeping—i.e., which hospitals and medical schools may fall within the Act’s operational permissions and compliance regime. For practitioners, the key point is that the legal status of an institution can affect whether certain activities are permitted, how authorisations are processed, and what regulatory expectations apply.
Because the Notification is structured as a “Schedule” listing approved institutions, it functions as a living document. It is amended over time to add, remove, or update the list of approved hospitals and medical schools. This means that legal advice often requires checking the latest version (including the most recent amendments) rather than relying on older citations.
What Are the Key Provisions?
Section 1 (Citation). Section 1 provides the short citation of the instrument: the “Medical (Therapy, Education and Research) (Approved Hospitals and Medical Schools) Notification 2010.” While this is standard drafting, it matters for legal referencing, especially when cross-referencing the Notification in compliance documents, internal policies, or regulatory submissions.
Section 2 (Approved hospitals and medical schools). Section 2 is the substantive provision. It empowers and records the Minister’s declaration that certain institutions are approved. Specifically, the Minister declares (a) the hospitals specified in Part 1 of the Schedule to be approved hospitals for the purposes of the Act, and (b) the medical schools specified in Part 2 of the Schedule to be approved medical schools for the purposes of the Act. This “two-part” approach is important: hospitals and medical schools are treated as distinct categories, each with its own list.
The Schedule (the operative list). Although the extract provided focuses on Section 2 and the existence of the Schedule, the Schedule is where the legal effect is realised. The Schedule contains the actual names of the approved hospitals and approved medical schools, divided into Part 1 and Part 2. In practice, the Schedule is the document that lawyers and compliance officers consult to confirm whether a particular institution is covered.
Amendment mechanism and version control. The Notification has been amended multiple times since its original issuance in 2010. Amendments are reflected through subsidiary legislation instruments (e.g., S 575/2010, S 562/2015, S 566/2018, S 412/2024) and later consolidated into the 2025 Revised Edition. For legal work, this means that the “current version” date is not a mere formality. If an institution was added after a particular date, advice given using an older version could be inaccurate. Conversely, if an institution was removed or reclassified, continued reliance on outdated lists could create compliance risk.
How Is This Legislation Structured?
This Notification is structured in a conventional subsidiary-legislation format: a short citation section, a key declaratory section, and a Schedule containing the lists of approved institutions. The extract indicates that the Schedule includes (at least) a “Comparative Table” and “Legislative History” features in the online publication interface, but the legally operative content is the Schedule’s Parts 1 and 2.
From a practitioner’s perspective, the structure is straightforward:
- Section 1 sets out the citation.
- Section 2 records the Minister’s declaration and links approval to the Schedule.
- Part 1 of the Schedule lists approved hospitals.
- Part 2 of the Schedule lists approved medical schools.
There are no “Parts” of the Notification itself (as indicated in the metadata), which reinforces that the instrument is essentially a designation list under the parent Act.
Who Does This Legislation Apply To?
The Notification applies to institutions—specifically, hospitals and medical schools—that are listed in the Schedule as approved for the purposes of the Medical (Therapy, Education and Research) Act 1972. The legal effect is therefore primarily institutional, not individual. However, the consequences are felt by individuals working within those institutions (e.g., clinicians, researchers, administrators) because their lawful activities may depend on the institution’s approved status.
In addition, the Notification indirectly affects third parties who interact with approved institutions in the relevant regulatory context. For example, if a research project or educational activity relies on the Act’s framework, counterparties may need to verify that the participating hospital or medical school is approved. Lawyers advising sponsors, research collaborators, or institutional ethics/compliance committees should therefore treat the Schedule as a due diligence checklist item.
Why Is This Legislation Important?
Although the Notification is short, it is legally significant because it determines eligibility. In regulatory regimes involving human tissue for therapy, education, and research, the law often draws distinctions between approved and non-approved institutions. Approval status can be the difference between activities being within a statutory pathway versus being outside it (or requiring additional permissions). Accordingly, this Notification is a key compliance reference point for healthcare and academic institutions.
From an enforcement and risk perspective, the importance lies in the “paper trail” and auditability of compliance. If an institution is not approved, it may face regulatory exposure for activities that rely on the Act’s permissions. Even where operational practices are otherwise sound, legal compliance can fail if the institution’s status is not aligned with the statute and its subsidiary instruments.
Finally, the Notification’s amendment history underscores that approval is not static. Institutions may be added as they meet requirements, or changes may occur due to administrative updates, restructuring, or policy refinement. Practitioners should therefore build a habit of checking the latest revised edition or current version—particularly when advising on new projects, collaborations, or institutional governance changes.
Related Legislation
- Medical (Therapy, Education and Research) Act 1972 (Authorising Act; referenced in the Notification, including Section 2B as indicated in the online search context)
Source Documents
This article provides an overview of the Medical (Therapy, Education and Research) (Approved Hospitals and Medical Schools) Notification 2010 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.